Aligos Therapeutics

0 followers

Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.

Industries

Employees

51-200

Links


Org chart

Lawrence M. Blatt
Chief Executive Officer
Collapse
Lesley Ann Calhoun
EVP, Chief Financial Officer
Lucinda Y. Quan
EVP, Chief Business Officer & General Counsel
Julian A. Symons
EVP & Chief Scientific Officer
Dave Smith
Executive Vice President
Kha le
Executive Director
David B. Smith
EVP & Head of Chemical Operations

Board & advisors

Jack B. Nielsen
Chairman / Lead Director
James Scopa
Director